Predispensing of antivirals to high-risk individuals in an influenza pandemic
about
Antiviral usage for H1N1 treatment: pros, cons and an argument for broader prescribing guidelines in the United States.Pre-dispensing of antivirals to high-risk individuals in an influenza pandemic.Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.
P2860
Predispensing of antivirals to high-risk individuals in an influenza pandemic
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Predispensing of antivirals to high-risk individuals in an influenza pandemic
@ast
Predispensing of antivirals to high-risk individuals in an influenza pandemic
@en
type
label
Predispensing of antivirals to high-risk individuals in an influenza pandemic
@ast
Predispensing of antivirals to high-risk individuals in an influenza pandemic
@en
prefLabel
Predispensing of antivirals to high-risk individuals in an influenza pandemic
@ast
Predispensing of antivirals to high-risk individuals in an influenza pandemic
@en
P2860
P356
P1433
P1476
Predispensing of antivirals to high-risk individuals in an influenza pandemic
@en
P2093
Edward Goldstein
Justin O'Hagan
P2860
P304
P356
10.1371/CURRENTS.RRN1007
P577
2009-08-21T00:00:00Z